dihydralazine has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckett, AH; Frohn, MJ; Jones, GR | 1 |
| Boeryd, B; Hagmar, B; Johnsson, G; Ryd, W | 1 |
2 other study(ies) available for dihydralazine and EHS Tumor
| Article | Year |
|---|---|
Liminal therapy: a strategy for the complete and selective destruction of malignant tissue in situ.
Topics: Animals; Antineoplastic Agents; Cell Survival; Dihydralazine; Drug Resistance; Energy Metabolism; Humans; Hydralazine; Isoproterenol; Mice; Naphazoline; Neoplasms; Oxygen; Oxygen Consumption; Phenylephrine; Sarcoma, Experimental; Time Factors; Vasopressins | 1984 |
Alteration of metastases distribution by vaso-dilating drugs.
Topics: Animals; Dihydralazine; Hydralazine; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred CBA; Neoplasm Metastasis; Phenoxybenzamine; Sarcoma, Experimental; Vasomotor System | 1975 |